CollPlant Biotechnologies (CLGN) Shares Outstanding (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Shares Outstanding (Entity) of $551666.0 for Q4 2022, little changed on a QoQ basis from $554324.0 in Q3 2022, and up 10.68% year-over-year from $498449.0 in Q4 2021.
CollPlant Biotechnologies (CLGN) Shares Outstanding (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies' Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $551666.0 for Q4 2022.
- Quarterly Shares Outstanding (Entity) rose 10.68% year-over-year to $551666.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $551666.0 (up 10.68% YoY) and the FY2022 annual result came in at $551666.0, up 10.68% from the prior year.
- Shares Outstanding (Entity) was $551666.0 for Q4 2022 at CollPlant Biotechnologies, roughly flat from $554324.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $554324.0 in Q3 2022 and bottomed at $37.0 in Q2 2022.
- A 5-year average of $328850.3 and a median of $332981.0 in 2020 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2018 — Shares Outstanding (Entity) jumped 64.6% — and 2019, when it rose 1.5%.
- CollPlant Biotechnologies' Shares Outstanding (Entity) stood at $219229.0 in 2018, then climbed by 13.73% to $249319.0 in 2019, then surged by 38.12% to $344348.0 in 2020, then jumped by 44.75% to $498449.0 in 2021, then climbed by 10.68% to $551666.0 in 2022.
- Business Quant data shows CLGN's Shares Outstanding (Entity) at $551666.0 in Q4 2022, $554324.0 in Q3 2022, and $37.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 198.10 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | 13.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 13.75 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Sep 30, 2025 | 12.72 Mn |
| Jun 30, 2025 | 11.84 Mn |
| Mar 30, 2025 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Sep 30, 2024 | 11.45 Mn |
| Jun 30, 2024 | 11.45 Mn |
| Mar 31, 2024 | 11.45 Mn |
| Dec 31, 2023 | 11.39 Mn |
| Sep 30, 2023 | 11.44 Mn |
| Jun 30, 2023 | 510.00 |
| Mar 31, 2023 | 11.27 Mn |
| Dec 31, 2022 | 11.03 Mn |
| Sep 30, 2022 | 11.09 Mn |
| Jun 30, 2022 | 740.00 |
| Mar 31, 2022 | 10.78 Mn |
| Dec 31, 2021 | 9.97 Mn |
| Sep 30, 2021 | 10.50 Mn |
| Jun 30, 2021 | 760.00 |